Status:
UNKNOWN
Clinical Efficacy of Silk Sericin Dressing With Collagen for Split-thickness Skin Graft Donor Site Treatment
Lead Sponsor:
Chulalongkorn University
Conditions:
Wound Heal
Wound Surgical
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To examine the efficacy and safety of sericin dressing with collagen in STSG donor site treatment comparing with Bactigras®. Around 30 patients will be enrolled in this study.
Detailed Description
Wounds are a public health problem found worldwide that associated with both clinical and economic burdens. Although several wound dressings are available, some limitations of those dressings still ex...
Eligibility Criteria
Inclusion
- Patients who have STSG donor site wounds on the thigh area
- Age more than 18 years old
- The split-thickness skin graft is harvested for the first time at the investigated area.
- Patients who are able to communicate with the Thai language
- Willingness to participate
Exclusion
- Patient with a mental disorder or immunocompromised diseases
- Patients who cannot or not willing to follow the protocol
- Known sensitivity or allergy to sericin, chlorhexidine, and collagen
- Pregnancy or lactation
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04743375
Start Date
February 1 2021
End Date
December 1 2021
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chulalongkorn Hospital
Bangkok, Thailand, 10330